Emerging Research and News in Prostate Cancer Imaging — March 2025

Touching on a variety of topics in prostate cancer imaging, ranging from monitoring of prostate MRI exams to reduce contrast use to a new meta-analysis on AI and bpMRI for csPCa detection and FDA approval of Gozellix for the preparation of the PSMA PET agent ⁶⁸Ga gozetotide, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for March 2025.